
Docebo rose 31.7% from $21.13 to $27.82, ahead of the S&P 500's +4.7%. Its worst day was Feb 18 (−13.8%), and its low came Apr 10 at $14.70.
Nov 21, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Docebo shares fell 13.8%, while the S&P 500 rose 0.5%.
−13.8%, the year's worst day, on 897K shares, the year's heaviest volume · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
EPS of $0.45 beat the $0.33 estimate on $63.0M revenue (est. $62.6M); FY revenue guidance of $267.5M–$269.5M against the $268.8M consensus.
−3.0% · S&P 500 −0.5%
Docebo shares rose 20.4%, while the S&P 500 fell 0.1%.
+20.4%, the year's best day · S&P 500 −0.1%
Docebo closed at its lowest level of the year, 30.4% below where the year started.
−8.5% · S&P 500 −0.1%
EPS of $0.34 beat the $0.34 estimate on $65.6M revenue (est. $65.3M); Q2 revenue guidance of $66.7M–$66.9M against the $67.0M consensus.
+1.1% · S&P 500 +0.8%
Docebo shares fell 11.3%, while the S&P 500 fell 0.7%.
−11.3% · S&P 500 −0.7%
Docebo shares rose 9.9%, while the S&P 500 fell 1.0%.
+9.9% · S&P 500 −1.0%
EPS of $0.35 beat the $0.30 estimate on $68.7M revenue (est. $66.8M); FY revenue guidance of $274.5M–$276.5M against the $272.0M consensus.
+8.9% · S&P 500 +0.6%
EPS of $0.55 beat the $0.46 estimate on $70.3M revenue (est. $69.6M); Q4 revenue guidance of $71.9M–$72.1M against the $71.6M consensus.
−4.7% · S&P 500 +0.3%
Where it ended: a close of $27.82 on Nov 20, 2026. Up next: Q4 2026 earnings on Feb 26, 2027 (EPS est. $0.55, revenue est. $72.1M).
Nothing in the past 12 months.
All DCBO dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for DCBO and SPY from Benzinga historical bars. Not investment advice.